To demonstrate the effect of resveratrol on Notch signaling in MG-63 and U2OS osteosarcoma cell lines. Methods: Cell Counting Kit 8 reagent was used to analyze cell proliferation while TRIzol® reagent was employed for the extraction of total RNA. High Capacity cDNA reverse transcription chain reaction kit was used to transcribe 2 μg RNA. Western blot analysis was performed to examine Hes1 and Hey1 expression. Results: The results revealed that resveratrol treatment exhibited dual mechanisms of action on the activation of Notch signaling in osteosarcoma cells. The osteosarcoma cell lines, MG-63 and U2OS, when exposed to 20 µM concentration of resveratrol for 48 h showed significant toxicity compared to untreated cells. However, 30 µM concentration of resveratrol induced higher toxicity which was lethal to cell growth. The results from RT qPCR and Western blot data revealed a concentration-dependent effect of resveratrol on the expression of Notch signaling genes including Hes1, Hes5, Hey1, Hey2 and HeyL in U2OS cells. Treatment of U2OS cells with 20 µM concentration of resveratrol for 48 h induced a marked increase in the expression of Hes1, Hes5, Hey1, Hey2 and HeyL mRNA compared to the untreated cells. However, at a concentration of 30 µM, resveratrol inhibited the activation of Notch signaling pathway. This was evident by a decrease in the expression of Hes1, Hes5, Hey1, Hey2 and HeyL, Notch signaling target genes. Conclusion: Resveratrol plays an important role in the activation of Notch signaling pathway and may be of therapeutic benefit in the treatment of osteosarcoma.
INTRODUCTION
Osteosarcoma one of the frequently detected malignant bone tumors in adolescents and children is associated with enhanced local growth and metastasis [1] . In the USA alone, more than 400 new cases of pediatric osteosarcoma are detected every year [2] . The commonly used treatment strategies for osteosarcoma include chemotherapy and surgical excision, but the rate of prognosis is very poor [3] . Therefore, efforts for discovery and screening of novel molecules for osteosarcoma treatment are constantly being performed throughout the globe. During the last three decades various molecules have been developed for the treatment of osteosarcoma which led to overall survival rate of more than 50 %. Some of these molecules include methotrexate, resveratrol, ifosfamide cisplatin, and etoposide [4] . However, it has been reported that patients with metastatic or recurrent tumors show poor prognosis [5, 6] . Therefore, it is believed that knockdown of signaling pathways can provide promising results for the treatment of osteosarcoma.
The process of proliferation, apoptosis and cell differentiation in various types of cancers is regulated by Notch signaling pathway [7] [8] [9] . It is reported that Notch receptors interact with the corresponding ligands after cleavage in the presence of proteolytic enzymes. These alterations induce the secretion of intracellular domain of Notch which is translocated to the nucleus where it complexes leading to the activation of transcription specific target genes [10, 11] . These target genes include hairy and enhancer of split (Hes) and Hes related with YRPW motif (Hey). Down-regulation of the activity of Notch genes has been detected in various malignancies like colon [12, 13] , pancreatic [14, 15] and cervical [16] cancer. Furthermore, various studies have demonstrated reduced activity of Notch in osteosarcoma [17, 18] . Therefore, the present study was designed to investigate the effect of resveratrol on the activity of the Notch signaling pathway in U2OS osteosarcoma cell lines.
Resveratrol has shown promising results in the suppression of cellular events involved in the beginning and progression of tumors in several types of cells lines [19, 20] . It also increases the immunity of mice by promoting the expression of cytokines including interleukin (IL)-12 and interferon (IFN)-γ [21] . In addition, resveratrol treatment induces inhibition of cell growth and proliferation in breast carcinoma cell lines [22] . The synthetic derivatives of resveratrol have also been shown to possess potent activity against tumor cell lines including MCF-7 human breast adenocarcinoma cell line [23, 24] . The present study demonstrates the effect of resveratrol on Notch signaling pathway activation in MG-63 and U2OS, osteosarcoma cell lines. The results revealed that resveratrol treatment exhibited dual effect on the activation of Notch signaling pathway.
EXPERIMENTAL Reagents
Resveratrol was obtained from Sigma (St. Louis, MO) and was dissolved in dimethyl sulfoxide (DMSO, Sigma) to prepare the stock solution.
Cell lines and culture
Human osteosarcoma cell lines MG-63 and U2OS were obtained from the American Type Culture Collection (ATCC, Rockville, MD, USA). The cells were grown in DMEM with 10 % FBS and cultured in 5 % CO 2 atmosphere at 37 o C. The viability of the cells was analyzed using trypan blue staining (Invitrogen Life Technologies).
Cytotoxicity assay
MG-63 and U2OS osteosarcoma cells were distributed at a density of 2 x 10 5 cells per well onto the 96 well culture plates. To each of the well different concentrations of resveratrol were added and the cells were cultured for 48 h. The control cells were treated with DMSO alone and then incubated for 48 h. After incubation, 20 μL of the Cell Counting Kit 8 reagent Sigma (St. Louis, MO), was added to each well. The cells were again incubated for 1 h at 37 o C under humidified atmosphere of 5 % CO 2 . The microplate reader (Thermo Fisher Scientific, Waltham, MA, USA) was used to measure the optical density of each well at 465 nm.
Quantitative polymerase chain reaction (qPCR)
From the resveratrol treated or untreated cells, total RNA was extracted using TRIzol® reagent (Invitrogen Life Sciences, Carlsbad, CA, USA) according to the manufacturer's instructions. The High Capacity cDNA Reverse Transcription kit (Applied Biosystems, Inc, Foster City, CA, USA) was used to transcribe 2 μg RNA samples to cDNA according to the manual protocol. QuantiTect SYBR Green PCR kit (Qiagen, Tokyo, Japan) was used for the quantification of transcripts by qPCR whereas the analysis was performed using Applied Biosystems® 7500 Fast Real Time PCR system (Applied Biosystems Inc.). The PCR reactions were carried out at 95 o C for 10 min, then 40 cycles of 95 o C for 30 sec and 60 o C for 1 min. The data obtained was then analyzed using ABI Prism® analysis software (Applied Biosystems, Inc.).
Western blot analysis
U2OS and Saos 2 cells were washed three times with cold PBS and then treated with 120 μl radioimmuno precipitation assay buffer [50 mM Tris HCl, pH 6.8; 0.1% SDS, 150 mM NaCl, 1 mM EDTA, 0.1 mM Na 3 VO 4 , 1 mM sodium fluoride (NaF), 1 % Triton X 100, 1 % NP 40, 1 mM dithiothreitol, 1 mM PMSF, 1 μg/mL aprotinin, 1 μg/mL leupeptin and 1 μg/mL pepstatin A] for cell lysis. Cell lysates were centrifuged at 12,000 x g for 30 min to get the clear supernatant. For the purpose of the determination of the concentration of proteins bicinchoninic acid assay (Sigma Aldrich). The proteins were separated by electrophoresis on SDS polyacrylamide gel and then transferred onto polyvinylidene difluoride membranes. The membranes were blocked with 5 % skimmed milk in buffer [ 
Statistical analysis
Analysis of the obtained data was performed using a statistical software (SPSS Inc, Chicago, IL, USA). All the data are presented as mean ± standard deviation (SD), and for numerical data analysis, Student's t-test or one-way analysis of variance (ANOVA) was used. Differences were considered statistically significant at p < 0.05.
RESULTS

Effect of resveratrol on the osteosarcoma cell lines
The osteosarcoma cell lines, MG-63 and U2OS were exposed to a range of resveratrol concentrations from 5 to 30 µM for various time intervals. The results revealed a concentration and time dependent increase in toxicity to MG-63 and U2OS cells. The concentration at which the resveratrol induced toxicity in both the cell lines was significant compared to untreated cells at 20 µM after 48 h (p < 0.01; Fig 1) . However, when MG-63 and U2OS cells were exposed to 30 µM concentration of resveratrol for 48 h it induced higher toxicity which was lethal to cell growth (p < 0.01; Fig 1) .
Figure 1:
Resveratrol treatment reduces the viability of osteosarcoma cells. MG-63 and U2OS osteosarcoma cells were exposed to different doses of resveratrol for various time intervals
Effect of resveratrol on the expression of Notch target genes
We used RT qPCR and western blot analyses to examine the effect of resveratrol on the activation of Notch signaling pathway. The results from RT qPCR analysis revealed a concentration dependent effect of resveratrol on the expression Notch signaling genes including Hes1, Hes5, Hey1, Hey2 and HeyL, in U2OS cells. Treatment of U2OS cells with 20 µM concentration of resveratrol for 48 h induced a marked increase in the expression of Hes1, Hes5, Hey1, Hey2 and HeyL mRNA compared to the untreated cells (p < 0.05; Fig 2A) . These results were further confirmed using western blot analysis.
Inhibition of Notch target gene expression by resveratrol at high concentration
Exposure of the U2OS osteosarcoma cells to resveratrol at 50 µM concentration led to a marked decrease in the expression of Hes1, Hes5, Hey1, Hey2 and HeyL, Notch target genes (p < 0.05; Fig 3A) . To confirm the inhibitory effect of resveratrol at 30 µM concentration western blot analysis was performed. The results from western blot analysis also revealed a significant decrease in the expression of Hes1 and Hey1 genes following 48 h of the resveratrol treatment ( Fig 3B) . 
DISCUSSION
Exposure of the tumor cells to resveratrol led to the suppression of cellular processes associated with the beginning and progress of tumors [19, 20] .
Resveratrol treatment enhances immunity of mice by increasing the expression of cytokines like interleukin (IL)-12 and interferon (IFN)-γ [21] . In addition, resveratrol treatment inhibits cell growth and proliferation in breast carcinoma cell lines [22] . The present study demonstrates the role of resveratrol in the activation of Notch activity in osteosarcoma cells. The results from the present study showed that resveratrol induced toxicity in MG-63 and U2OS osteosarcoma cell lines significantly compared to untreated cells at 20 µM concentration after 48 h. However, at 30 µM concentration, resveratrol induced higher toxicity which was lethal to cell growth.
It is reported that Notch activity leads to the development of tumors in osteosarcoma cells [18] . The activity of Notch1 in osteosarcoma cells plays an important role in the process of tumor cell invasion and tissue metastasis [25] . Studies have been performed which clearly demonstrate that downregulation of Notch signaling pathway inhibits the proliferation rate of cancer cells in vitro and tumor growth in vivo [26] .
The present study reveals that resveratrol treatment exhibits a concentration dependent effect on toxicity in osteosarcoma cells. Exposure of the osteosarcoma cells to resveratrol up to 20 μM significantly increased the expression of Hes1, Hes5, Hey1, Hey2 and HeyL, Notch target genes after 48 h. These findings revealed that concentration of resveratrol required for induced activation of Notch signaling pathway is 20 μM.
However, when the osteosarcoma cells were exposed to higher concentration (30 μM) of resveratrol, the expression levels of Notch genes was reduced significantly. Therefore, the data from the present study demonstrates that resveratrol induced cytotoxicity in the osteosarcoma cells at higher doses may be associated with the suppression of Notch signaling pathway.
CONCLUSION
Resveratrol exhibits dual role in the activation of Notch signaling pathway by promoting its activation at low doses and inhibiting it at higher doses. Therefore, the drug is a potential candidate for the treatment of breast cancer.
